Cargando…
Commonly integrated epigenetic modifications of differentially expressed genes lead to adaptive resistance in cancer
AIM: To investigate the integrated epigenetic regulation of acquired drug resistance in cancer. MATERIALS & METHODS: Our gene expression data of five induced drug-tolerant cell models, one resistant cell line and one publicly available drug-resistant dataset were integrated to identify common di...
Autores principales: | Emran, Abdullah Al, Marzese, Diego M, Menon, Dinoop R, Hammerlindl, Heinz, Ahmed, Farzana, Richtig, Erika, Duijf, Pascal, Hoon, Dave SB, Schaider, Helmut |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595545/ https://www.ncbi.nlm.nih.gov/pubmed/31070054 http://dx.doi.org/10.2217/epi-2018-0173 |
Ejemplares similares
-
Epigenetics and metabolism at the crossroads of stress-induced plasticity, stemness and therapeutic resistance in cancer
por: Ravindran Menon, Dinoop, et al.
Publicado: (2020) -
Distinct histone modifications denote early stress-induced drug tolerance in cancer
por: Emran, Abdullah Al, et al.
Publicado: (2017) -
Magnolol induces cell death through PI3K/Akt‐mediated epigenetic modifications boosting treatment of BRAF‐ and NRAS‐mutant melanoma
por: Emran, Abdullah Al, et al.
Publicado: (2019) -
Emerging roles of H3K9me3, SETDB1 and SETDB2 in therapy-induced cellular reprogramming
por: Torrano, Joachim, et al.
Publicado: (2019) -
Tumor cell-intrinsic phenotypic plasticity facilitates adaptive cellular reprogramming driving acquired drug resistance
por: Hammerlindl, Heinz, et al.
Publicado: (2017)